Revenue
2023
2024
2025
2026
OKYO Pharma Ltd (OKYO)
Price$1.57Cached quote
Net income
2020
2021
2022
2023
2024
2025
2026
Free cash flow
2021
2022
2023
2025
2026
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — |
| Research & development | $1.8M | $2.3M | $8.2M | $6.3M | $1.6M | $348,347 | $518,098 |
| Operating expenses | $8.5M | $4.8M | $7.5M | $6.8M | $4.6M | $3.0M | $1.0M |
| Operating income | −$8.5M | −$7.1M | −$15.7M | −$13.2M | — | — | — |
| EBITDA | −$8.5M | −$7.1M | −$15.7M | −$13.2M | — | — | — |
| Net income | −$8.9M | −$4.7M | −$16.8M | −$13.3M | −$5.4M | −$3.4M | −$1.5M |
| Basic EPSper basic share | -$0.24 | -$0.20 | -$0.57 | -$0.61 | -$0.36 | -$0.32 | — |
| Diluted EPSper diluted share | -$0.24 | -$0.20 | -$0.57 | -$0.61 | -$0.36 | -$0.32 | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
CERRONE GABRIELE M | 10.83M |
Woodline Partners LP | 3.65M |
Stonepine Capital Management, LLC | 863K |
Maven Securities LTD | 809.32K |
Balyasny Asset Management L.P. | 580.6K |
Opaleye Management Inc. | 375.2K |
JACOB GARY S | 108.92K |
UBS Group AG | 55.01K |
XTX Topco Ltd | 37.77K |
CHOREO, LLC | 33.26K |
Quantinno Capital Management LP | 33.26K |
BRANCACCIO JOHN P | 30.2K |
Shah Keeren Rameshchandra | 16.67K |
Simon Willy Jules | 15.38K |
Cerity Partners LLC | 12.81K |
GEODE CAPITAL MANAGEMENT, LLC | 12.09K |
RENAISSANCE TECHNOLOGIES LLC | 11.2K |
JANE STREET GROUP, LLC | 10.3K |
Steward Partners Investment Advisory, LLC | 6K |
EFG International AG | 923 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data